Univo Pharmaceuticals Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
UNVO
IL0010935588
Biotechnology & Medical Research
Sales 2019 | 0.82 3.12 68.73 | Sales 2020 | 33.68 127.38 2.81K | Capitalization | 75.1M 284M 6.26B |
---|---|---|---|---|---|
Net income 2019 | -11M -41.6M -917M | Net income 2020 | - 0 0 | EV / Sales 2019 | 3,55,43,010 x |
Net cash position 2019 | 22.82M 86.31M 1.9B | Net Debt 2020 | 4.12M 15.58M 344M | EV / Sales 2020 | 23,52,105 x |
P/E ratio 2019 * |
-
| P/E ratio 2020 |
-
| Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 59.28% |
Managers | Title | Age | Since |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 04/93/04 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01/22/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15/19/15 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 04/93/04 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.05% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |